Announcements Trials
Browse Landscape

Status

No longer available 67Available 29Approved for marketing 15Temporarily not available 3

Sponsor Class

INDUSTRY 6OTHER 3

Study Type

Expanded_access 3

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

KRAS G12V Mutant Advanced Epithelial Cancers 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

pembrolizumab 1Insulin Infusion Systems 1Gemcitabine 1Erlotinib Hydrochloride 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Temporarily not available × OTHER × Expanded_access × Clear all
NCT05389514 2025-11-20

Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors

Providence Health & Services

Temporarily not available

KRAS G12V Mutant Advanced Epithelial Cancers

NCT02011880 2013-12-13

Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast Cancer

Shanghai University of Traditional Chinese Medicine

Temporarily not available
Breast

Breast Neoplasms

NCT01297101 2011-02-16

Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy

Shanghai Chest Hospital

Temporarily not available
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡